Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Sana Biotechnology, Inc. | Director | Common Stock | 5.79M | $22.5M | $3.89 | Oct 7, 2024 | Direct |
Lyell Immunopharma, Inc. | Director | Common Stock | 4.69M | $10.7M | $2.28 | Jun 14, 2024 | Direct |
AGILENT TECHNOLOGIES, INC. | Director | Common Stock | 25K | $3.68M | $147.48 | Mar 15, 2024 | Direct |
Lyell Immunopharma, Inc. | Director | Option (right to buy) | 130K | Jun 14, 2024 | Direct | ||
Sana Biotechnology, Inc. | Director | Stock Option (Right to Buy) | 65K | Jun 6, 2024 | Direct |